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Light-chain amyloidosis (AL) is adevastatingprotein-misfolding diseasecharacterizedby abnormal proliferationof plasma cells
in the bone marrow that secrete monoclonal immunoglobulin light chains that misfold and form amyloid ﬁbrils, thus causing
organ failure and death. Numerous reports on different protein-misfolding diseases show that soluble oligomeric species
populated by amyloidogenic proteins can be quite toxic to cells. However, it is not well established whether the soluble
immunoglobulin light-chain species found incirculation inpatients with AL are toxic to cells intargetorgans. We determined the
cellular toxicity of two well-characterized light-chain variable domain proteins from cardiac AL patients and their corresponding
germline protein, devoid of somatic mutations. Our results show that the soluble form of the AL proteins we characterized are
toxic to cardiomyocytes, and that the species found in cell culture correspond, for the most part, to the species present
in circulation in these patients.
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There are 420 human amyloid diseases characterized by
misfolding of otherwise native protein precursors that give
rise to the formation of amyloid ﬁbrils. These diseases can be
divided by localized (Alzheimer’s disease (AD)) or systemic
(light-chain amyloidosis (AL)) deposition. Historically, the
observation of end-stage amyloid deposits in biopsies and
postmortem specimens led to the assumption that amyloid
accumulation alone can explain the progression of amyloid
diseases. However, a large number of reports now suggests
that monomeric and soluble intermediate species (usually
referred to as protoﬁbrils
1) are responsible for the major
cytotoxicity in amyloid diseases. An early AD study by Hartley
et al.
2 demonstrated that low-molecular-weight Ab (LMW Ab)
andprotoﬁbrils induced toxicity in mixedbrain cultures without
an evident increase in ﬁbril formation, suggesting that the
neurotoxicity of LMW Ab and protoﬁbrils cannot be explained
by conversion to ﬁbrils.
More recently, Lesne et al.
3 found that extracellular
accumulationof56-kDasolubleAboligomerscausedmemory
deﬁcits in middle-aged AD transgenic animals. In the case of
systemic, familial amyloid polyneuropathy/cardiomyopathy
caused by mutant Transthyretin (TTR), Reixach et al.
4
conducted a cell culture-based analysis of the effect of
puriﬁed TTR species on the viability of cells in culture. Their
ﬁndings indicate that neither TTR ﬁbrils nor soluble aggre-
gates 4100kDa were toxic to the human neuroblastoma cell
line IMR-32.
Pokrzywa et al.
5 developed a Drosophila model for
TTR-associated amyloidosis. The authors showed that ﬂies
expressing high TTR levels had a larger proportion of
high-molecular-weight aggregates that are assumed to be
less toxic. The authors hypothesize that there is an optimal
concentration, speciﬁc to each mutated variant of TTR that
determines the rate of toxic aggregate formation and
consequently its effect on the phenotype, a notion consistent
with earlier studies in cultured cells.
AL is a devastating amyloid disease characterized by the
abnormal proliferation of plasma cells in the bone marrow that
secrete free immunoglobulin light chains that circulate as
monomersanddimers.
6Theselightchainsmisfoldasamyloid
ﬁbrils, generating toxic species that affect vital organs such as
the kidney, heart, and liver, thus causing organ failure and
death.
7 An early observation made by Kyle et al.
8 indicated
that AL patients can achieve resolution of their nephrotic
syndrome after treatment while presenting more extensive
amyloid deposition than what was initially observed in the
biopsied tissue. Recent studies have reported that soluble
light-chain species internalize into renal and cardiac cells
and cause alterations in cell homeostasis.
9–14 Brenner et al.
incubated urine-derived lightchainsfrom patientswith cardiac
ALinthepresenceofcardiomyocytes.Thelightchainsaltered
the cellular redox state of cardiomyocytes, with an increase in
intracellular reactive oxygen species and upregulation of
the cellular stress marker heme oxygenase-1. Impairment
of cardiomyocyte contractility and relaxation was also
observed.
9 It has been recently shown that urine-derived AL
light-chain proteins are toxic to cardiomyocytes by inducing
apoptosis through the p38 MAPK pathway. The light chain-
induced p38 activation depended on TAB1-mediated p38a
MAPK autophosphorylation. Treatment with a selective p38
MAPK inhibitor signiﬁcantly attenuated AL light chain-induced
oxidative stress, cellular dysfunction, and apoptosis.
14
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15 using human adipose
arterioles shows that the presence of urine-derived AL light
chainscauses elevatedlevels ofsuperoxide,impaired dilation
in response to sodium nitroprusside, and microvascular
dysfunction. All of the aforementioned cell and tissue culture
studies with AL proteins have been conducted using urine-
derived light chains from different AL patients, for whom
the primary sequence, the exact oligomeric state of the light
chains, and the folded state of these proteins were not
reported.
We hypothesize that soluble AL proteins are more cytotoxic
than their germline counterparts because of the presence of
somatic mutations in AL proteins that promote sampling of
toxic, partially folded states.
In this study, we characterized the cellular toxicity caused
by soluble recombinant, amyloidogenic light-chain variable
domain proteins, AL-09 and AL-12, and their corresponding
germline protein kI O18/O8, previously characterized in our
laboratory.
16–18 Both AL-09 and AL-12 are derived from
cardiac AL patients with very different survival after diagnosis.
Patient AL-09 was a 63-year-old man with a 14-year history of
monoclonal gammopathy of undetermined signiﬁcance.
19
AL-09 developed fatigue, anorexia, and claudication symp-
toms. The bone marrow presented with 60% of plasma cells;
hence, AL-09 was initially diagnosed with straight multiple
myeloma. Two months into treatment, he was diagnosed with
cardiac AL after showing signs of cardiomyopathy and atrial
ﬂutter. Amyloid was conﬁrmed in the cardiac tissue by biopsy.
AL-09 survived less than a year. At the time of AL-09 patient
diagnosis, the free light-chain assay was not available.
We recently determined the free light-chain level from
frozen plasma samples stored in our specimen bank.
20
AL-09 k-light-chain levels in serum were 201mg/dl.
Patient AL-12 was a 64-year-old woman diagnosed with
multiple myeloma/cardiac AL after presenting with symptoms
of hoarseness, trouble swallowing, 15lb weight loss, fatigue,
mild compensated congestive heart failure, and epigastric
pain. The presence of amyloid in the cardiac tissue was
conﬁrmed by biopsy. AL-12 survived 10 years. AL-12 patient
did not have the free light-chain assay performed on plasma
at the time of her illness. We also recently determined the free
light-chain level from frozen plasma samples stored in our
specimen bank.
20 AL-12 free k-light-chain levels in serum
were 10.1mg/dl.
AL-09 protein has seven somatic mutations from germline
kI O18/O8 and three nonconservative mutations, whereas
AL-12 protein has eight somatic mutations from kI O18/O8
and seven nonconservative mutations. For AL-09 and AL-12,
we cloned the variable domain region from the patients’
dominant clone light-chain cDNA into the bacterial plasmid
pET12a and expressed the variable domains in Escherichia
coli.
16,18 The variable domains (herein known as AL proteins
for simplicity) were puriﬁed and characterized extensively in
terms of their structure and ﬁbril-formation properties in our
previous studies.
17,18,21 We artiﬁcially generated a plasmid
corresponding to the germline protein kI O18/O8 with a
junction region JK2 by site-directed mutagenesis.
17 The
germline protein kI O18/O8has been used in previous studies
for comparative analysis in terms of protein structure, protein
stability, amyloid-formation properties, and, in this study,
cellular toxicity. The results of this study show that ALproteins
in solution induced signiﬁcant toxicity over time. We ﬁnd that
monomers and dimers are the predominant light-chain
species under cytotoxic conditions.
Results
Inﬂuence of amyloidogenic light chains on cell
viability. To detect changes in mitochondrial viability for
cardiomyocytes incubated with the three light chains tested,
we measure the percentage of living cells as a function
of soluble protein concentration (10–20mM) using the 3-(4,5-
dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide (MTT)
assay (Figure 1). There is a weak protein concentration
dependence linked to cellular viability for AL-12 and kI
O18/O8. Statistically signiﬁcant differences were found
for AL-12 after 72-h incubation between 10 and 14mM
(Po0.002), 10 and 16mM( Po0.006), 10 and 20mM
(Po0.01), and 12 and 14mM( Po0.01). For kI O18/O8,
statistically signiﬁcant differences were found after 72h
incubation between 10 and 16mM( Po0.03), and 10 and
20mM( Po0.004). No clear concentration dependence was
observed for AL-09. The only instances in which there is a
Figure 1 Cell viability in the presence of light chains followed by MTT assay. Protein concentrations from 10 to 20mM were incubated with HL-1 cardiomyocytes for
24–72h to determine cell viability. (a) kI O18/O8, (b) AL-09, and (c) AL-12. Samples were set up in triplicate, with average values shown from one assay
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Cell Death and Diseasestatistically signiﬁcant difference for AL-09 are after
24-h incubation between 10 and 16mM( Po0.03), after
48-h incubation between 10 and 16mM( Po0.05), and after
72-h incubation between 10 and 12mM( Po0.02), and
between 10 and 20mM( Po0.02). Using a concentration of
12mM, we observe differences in cell viability in the presence
of the three proteins. The difference in the number of
remaining living cells after 24h of protein incubation between
AL-09 and kI O18/O8 is signiﬁcant (Po0.03), although there
is a large error associated with the 24h incubation data
for all proteins. No statistically signiﬁcant difference was
seen between AL-09 and AL-12 after 24-h incubation
(Po0.10).There is an increase in cell viability after 48h of
incubation for all proteins. The increase in cell viability
between 24 and 48h in the presence of AL-09 is the only
condition that shows statistical difference (Po0.03). After
72h of incubation (the conditions in which we see the most
signiﬁcant changes between proteins), only 38% of cells
remain alive in the presence of AL-09, followed by AL-12
(57% living cells), and kI O18/O8 (52% living cells)
(Figure 2). Statistically signiﬁcant differences were found
between the number of living cells in the presence of AL-09
and AL-12, and AL-09 and kI O18/08 (Po0.004 and
Po0.02, respectively) after 72-h incubation. In summary,
our MTT assay results suggest that AL-09 causes the largest
reduction in the viability of HL-1 cardiomyocytes.
Increased caspase activity in the presence of
amyloidogenic light chains. A more direct method to
determine induced cell death is to measure caspase
activity in the presence of light chains. The assay we
use is speciﬁc for caspases 2, 3, and 7. We observe no
protein concentration dependence on caspase activity in the
presence of light chains (Figure 3). No major differences in
caspase activity are observed between proteins and protein
concentrations after 24 and 48h of incubation. Seventy-two
hours seem to be the best incubation time to observe
differences in caspase activity. Some protein concentrations
for AL-12 and kI O18/O8 have baseline caspase activity
observed with cells alone.
We observe the largest difference in caspase activity with
12mM protein. After 72h of incubation with 12mM protein,
AL-09 presents the highest caspase activity, followed closely
by AL-12. We observe baseline caspase activity levels with
kI O18/O8 (comparable with cells alone, Figure 4). The
difference between caspase activity for AL-09 and kI O18/O8
and that between AL-12 and kI O18/O8 is statistically
signiﬁcant (Po0.008 and Po0.05, respectively). AL-09 and
AL-12 present similar caspase activities (Po0.4).
Biochemical characterization of cytotoxic species
populated by light chains. To determine the exact
oligomeric state of the species populated in cell culture, we
used size exclusion chromatography. In Figure 5a–c, we
observe three common peaks for media from cells incubated
with the three proteins. These peaks show apparent
molecular mass B12, 130, and 400kDa. The 12-kDa peak
is only present in samples with amyloidogenic light chains
Figure 2 Percentageof livingHL-1cardiomyocyteswhenincubatedwith12mM
soluble light-chain protein followed by MTT assay. Proteins were incubated with
cells for 24–72h. Samples were set up in triplicate in two independent assays with
the average values, error bars, and P-values shown. *Po0.03, **Po0.004,
***Po0.02
Figure 3 HL-1 cardiomyocytes caspase activity in the presenceof light chains. Protein concentrations of 10–20mM were incubatedwith cells for 24–72h. Reagentswere
added 1h before reading each plate. Samples were set up in triplicate with the average ﬂuorescence shown. (a) kI O18/O8, (b) AL-09, and (c) AL-12
Cytotoxicity of immunoglobulin light chains
LA Sikkink and M Ramirez-Alvarado
3
Cell Death and Disease(denoted as ‘monomer peak’ hereafter) and elutes at slightly
different volumes B12kDa for all proteins, possibly due to
the different monomer–dimer equilibrium that occurs at this
concentration for all proteins based on their dimer
dissociation constants.
17 The monomeric and 400-kDa
peaks do not show large changes in absorbance over the
course of the 72-h incubation. AL-09 and AL-12 show a slight
increase in the absorbance of the 130-kDa peak after 72h,
whereas kI O18/O8 shows a similar slight increase in the
130-kDa peak after 48h. As the media alone contain proteins
(as shown in Figure 5a–c), we performed western blot
analysis on the fractions corresponding to the different peaks
found by size exclusion chromatography to identify the
light-chain species observed in cell culture. We observe
immunoreactive protein around the 12-kDa (monomer)
peak for all proteins. AL-09 is the only protein that clearly
showed the presence of 400-kDa immunoreactive protein
(corresponding to a 33-mer) after 24h of incubation (AL-12
shows a faint band corresponding to the 33-mer
immunoreactive species after 48h) (Figure 5d–l). After
72h of incubation, all immunoreactive light-chain species
disappear from the media for AL-09 and AL-12, with some
faint bands from the monomer peak for kI O18/O8 still visible.
This is possibly because they are binding to the cell surface
and/or being internalized into cardiomyocytes, as has been
observed for recombinant full-length AL-09 and kI O18/O8
(Olatoye and Ramirez-Alvarado, unpublished observations).
Ourwesternblotresultssuggestthatmonomersanddimers
are the predominant species in cell culture for the proteins
analyzed in this study. The protein peak corresponding
Figure 4 Caspase activity detected in HL-1 cardiomyocytes with a protein
concentration of 12mM. Cells were incubated with protein for 24–72h. Reagents
were added 1h before reading plate. Average ﬂuorescence, error bars, and
P-values were calculated from triplicate samples from two independent assays.
*Po0.008, **Po0.05
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Figure 5 Solublelight-chainspeciesdetectedincellcultureanalyzedbyanalyticalsizeexclusionchromatographyandwesternblot.HL-1cardiomyocyteswereincubated
with 12mM protein for 24–72h. Samples were set up in triplicate and combined before injecting onto the analytical size exclusion column.The molecularmass corresponding
to the peaks was calculated using a standard curve described in the ‘Materials and Methods’ section. (a) kI O18/O8, (b) AL-09, and (c) AL-12. The molecular weight
corresponding to peaks of interest are shown. Western blot analysis shows immunoreactive kI O18/O8 (d, g, j), AL-09 (e, h, k), and AL-12 (f, i, l) species in cell culture.
Molecular weights denoted in the ﬁgure are expressed in kDa
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Cell Death and Diseaseto 130kDa is part of the media and does not contain any light-
chain species. Electron microscopy images of cell culture
samples in which cytotoxicity was observed do not show any
distinguishing features compared with the media alone,
conﬁrming our ﬁndings that the species found in cell culture
are soluble and are of LMW (data not shown). Fibril-formation
reactions followed by thioﬂavine T (ThT) ﬂuorescence in
an independent experiment showed no signs of amyloid
formation under conditions used in the cellular assays (371C,
72h) (Supplementary Figure 1).
Discussion
AL is a devastating amyloid disease characterized by
misfolding of light chains as amyloid ﬁbrils, thus causing
organ damage and death. The mechanisms underlying the
pathophysiology of AL remain largely unknown. In this study,
we showed that soluble, recombinant, immunoglobulin
light-chain variable domain proteins from AL patients have
large effects on cardiomyocyte viability, in agreement with a
recent report using urine-derived proteins.
14 We demon-
strated that the species populated are of LMW comprising
mostly monomers in equilibrium with dimers and soluble
33-mer species. Using the MTT assay reported by others to
assess the cytotoxicity of soluble amyloidogenic proteins,
4 we
observe large variability between our replicates for all proteins
after 24h incubation and an increase in cell viability after
48h (signiﬁcantly different only for AL-09), possibly due to the
reported errors associated with the process of solubilization
of the dark blue formazan produced in this assay and artifacts
associated with the proteins contained in the media.
22,23
Another way to measure cell viability is to determine the
lactate dehydrogenase (LDH) enzyme released into the
media. However, after an extensive optimization protocol,
we were unable to correlate LDH activity with cytotoxicity
on HL-1 cardiomyocytes because of the high LDH activity
calculated for cardiomyocytes alone in cell culture (see the
‘Materials and Methods’ section; Supplementary Figure 2), in
agreementwithobservations madein a recentreport studying
the possible anti-apoptotic effects of L-carnitine on cardio-
myocytes.
24 The AL proteins used in this study have 90%
sequence identity. After 72h of incubation with 12mM protein,
AL-09isthemostcytotoxicproteinbythetwomethodsusedin
this paper (MTT and caspase activity). AL-12 does not cause
a large effect in cell viability using MTT, but it induces high
caspase activity in cell culture close to the activity induced
by AL-09. The germline protein kI O18/O8, devoid of somatic
mutations, decreases cellular viability slightly, but does not
induce any additional caspase activity compared with cells
alone.The clinicalcharacteristics ofpatients AL-09 andAL-12
indicate that both had suffered severe cardiac damage when
initially diagnosed with cardiac AL. Patient AL-09 had higher
levels of free k-light chain in serum than did patient AL-12,
offering a possible explanation for the difference in the
severity of their disease. However, our studies were carried
out at the same concentration for both proteins, suggesting
that the cytotoxic potential of AL-09 does not depend entirely
on a high protein concentration.
Biophysical characterization of the proteins used in this
study has shown that although AL-09 and AL-12 present
similar thermodynamic stability, both AL proteins are
less stable than kI O18/O8. Crystal structures of AL-12 and
kI O18/O8 have shown that these proteins form the cano-
nical dimer interface observed in immunoglobulin light
chains.
17,18,21 However, AL-09 populates an altered dimer
interface
17 andforms ﬁbrils quite readilycompared with AL-12
and kI O18/O8 (Supplementary Figure 1). These previous
reports suggest that somatic mutations present in AL-09
cause the protein to dimerize in an altered conformation,
promoting misfolding and facilitating the formation of amyloid
ﬁbrils. The current study adds important information to the
characterization of these amyloidogenic light chains. It shows
that AL-09 is highly toxic to cardiomyocytes, suggesting that
the altered dimer interface allows intramolecular and inter-
molecular interactions that cause the protein not only to form
ﬁbrils quite readily but also most importantly to populate
soluble cytotoxic species. We identiﬁed light-chain species
corresponding to monomer and 33-mer present in cell culture
that seem to be responsible for the cytotoxicity observed in
this study. The use of size exclusion chromatography coupled
withwesternblottingwasparticularlyusefulasthemediaused
for these experiments have a high protein content and there
were no distinguishing features in the chromatogram of the
cytotoxic reactions other than the presence of the monomeric
peak. As we mentioned before, these monomeric species are
probably in equilibrium with dimeric species based on the
dissociation constants for these proteins.
17 Further studies
should be conducted to determine the role of the 33-mer
species in cytotoxicity. The monomeric and 33-mer species
would need to be puriﬁed from the media and re-incubated
with cardiomyocytes to establish their exact role in cytotoxi-
city. It would be important to determine whether these species
are made entirely of light chains or whether there are other
proteins associated with the 400-kDa assembly. Although we
observe small changes in the 130-kDa peak for all proteins,
this peak does not contain any light-chain species, and at this
point, we cannot conclude whether changes in the media
protein components at 130kDa are causing any change to the
light chains and have an inﬂuence on cell viability results. The
disappearanceoflight-chainspeciesfromthemediasuggests
that the protein is entering into the cells and promoting cell
death during the internalization process. In the future, it would
be important to study the cytotoxic effects of 72-h media
depleted of light-chain protein to prove this hypothesis. In
addition, future studies determining the cytotoxicity asso-
ciated with amyloid ﬁbrils from these proteins will help identify
the most cytotoxic species in cell culture for AL proteins.
AL-09 has three nonconservative mutations within or
adjacent to the dimer interface (namely N34I, K42Q, and
Y87H), whereas AL-12 has seven nonconservative mutations
throughout the protein structure (namely Y32H, S65R, D70H,
E81A, Q90E, N93Y, and Y96Q), three of them in the dimer
interface (Y32H, Q90E, and Y96Q). Previous sequence/
structure analysis performed in our laboratory found that the
number of nonconservative mutations in amyloidogenic
light chains do not determine their amyloidogenicity. Rather,
we proposed that the location of mutations confers the
proteins with their amyloidogenic potential.
20 The cytotoxicity
associated with AL-09 suggests that the speciﬁc location of
mutations within the dimer interface promotes the formation
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Cell Death and Diseaseof cytotoxic species. Future studies determining the role of
speciﬁc somatic mutations in cytotoxicity will be necessary to
fullyunderstandtheoriginofcytotoxicityinamyloidogeniclight
chains.
Materials and Methods
Cells. Mouse HL-1 cardiomyocytes were kindly provided by Dr. William
Claycomb.
25 Flasks were coated with ﬁbronectin and gelatin and cells were
maintained in Claycomb medium (Sigma, St. Louis, MO, USA) supplemented with
10% fetal bovine serum (FBS), 0.1mM norepinephrine dissolved in 30mM ascorbic
acid, 2mM L-glutamine, and 100Units/ml penicillin–streptomycin. Cells were
incubated at 371C with 5% CO2 as reported previously.
26
Protein preparation. kI O18/O8, AL-09, and AL-12 were expressed and
puriﬁed as reported previously.
16–18 In brief, the proteins were expressed in E. coli
BL21 (DE3) gold-competent cells at 301C, 250r.p.m. The cells were induced with
0.8M IPTG, harvested, and frozen at  201C. Thawed cells were treated with
osmotic shock. AL-09 was extracted from inclusion bodies using 6M urea, whereas
kI O18/O8 and AL-12 were extracted from periplasmic fractions. The proteins were
puriﬁed using size exclusion chromatography (HiLoad 16/60 Superdex 75 column)
on an AKTA FPLC (GE Healthcare, Piscataway, NJ, USA). Pure fractions were
collected,concentrated,and frozen.Proteinswere thawedimmediatelybefore each
assay. After ﬁltration, the protein concentration was determined as reported
previously.
18
Cell viability assays
Mitochondrial viability assay. Cardiomyocytes were plated (10000 cells per
ml) in a 96-well Costar polystyrene plate and allowed to grow for 2 days where they
reached 70% conﬂuency before addition of the soluble protein. For these assays,
we used supplemented Claycomb media without norepinephrine because the
ascorbicacidsolutionusedtopreparenorepinephrineinterfereswiththecellviability
reagents described below. Different soluble protein concentrations (10, 12, 14, 16,
and 20mM) were added to the cells. Each condition was set up in triplicate. Plates
were assayed 24, 48, and 72h after addition of the soluble protein. The cell
proliferation kit I (MTT) (Roche, Indianapolis, IN, USA) was used for this assay. In
brief, 10ml of MTT reagent was added per well and incubated at 371C, 5% CO2 for
4h. Next, 100ml of solubilization buffer was added to each well and incubated
overnight.PlateswerereadonaSpectraMax384PlateReader(MolecularDevices,
Sunnyvale, CA, USA) at 570 and 690nm. The 690-nm absorbance reading
(reference) was subtracted from the 570-nm absorbance reading for each well, and
the percentage of living cells was calculated using the following formula:
%living cells ¼
ðsample absorbance   blank absorbanceÞ
control absorbance   blank absorbance
 100;
whereblankabsorbanceisthemediaaloneandcontrolabsorbancecellswithmedia
alone. The average of the percentage of living cells was then calculated along with
S.D. Cells without protein were used as the reference for 100% living cells.
Data from two independent experiments were analyzed using the Microsoft Excel
2003 (Microsoft, Redmond, WA, USA) t-test for two samples assuming equal
variance tool to calculate P-values.
LDH assay. The 96-well Costar polystyrene plates were plated with 15625 cells
per ml 1 day before addition of the soluble protein with supplemented Claycomb
media (containing 10% FBS). Media were removed and the plate was washed with
1% FBS and norepinephrine-free media. Several soluble protein concentrations
(10, 12, 14, 16, and 20mM) were added to the cells with supplemented Claycomb
mediacontaining1%FBSandno norepinephrine. Sampleswereset upin triplicate.
Cells were incubated with the soluble protein for various time points (24, 48, and
72h). The assay was performed following LDH cytotoxicity detection kit protocol
(Clontech, Mountain View, CA, USA), with a few modiﬁcations. In brief, 200mlo f
media from each well was transferred to a new 96-well polystyrene plate and spun
at 300 g for 10min. Next, 100ml of supernatant was transferred to a new plate in
which we added 100ml of reaction mixture to each well, and incubated at room
temperature in the dark for 30min. The plate was read at 492 and 690nm on a
SpectraMax Plus 384 Plate Reader (Molecular Devices). The 690-nm reference
absorbance reading was subtracted from the absorbance at 492nm and the
average absorbance and S.D. were calculated for each triplicate. Cell membrane
integrity or percentage of LDH released could not be calculated because of
high-absorbance readings with cells alone.
Caspase activity assay. Cardiomyocytes were plated at 25000 cells per ml in
a 96-well clear bottom black polystyrene plate with 100ml of supplemented
Claycomb media with 1% FBS and no norepinephrine. Different protein
concentrations (10, 12, 14, 16, and 20mM) were immediately added to the
cardiomyocytes. Samples were set up in triplicate. Plates were incubated for 0, 24,
48, or 72h before following the assay protocol. Each plate was assayed using the
homogeneous caspase assay, ﬂuorimetric kit (Roche). In brief, 100ml of substrate
workingsolutionwasaddedtoeachwellandincubatedfor1–24hat371C,5%CO2.
The plate was read on the Analyst AD plate reader (Molecular Devices) at an
excitation wavelength of 485nm and an emission wavelength of 530nm. The
average ﬂuorescence and S.D. were calculated for each sample. Data from two
independent experiments were analyzed using the Microsoft Excel 2003 Student’s
t-test tool for two samples assuming equal variance to calculate P-values.
Analytical size exclusionchromatography. Beforeproteins were incubated
with the media and cells, we performed analytical size exclusion chromatography
studies in the buffer to conﬁrm that all proteins were monomeric. The oligomeric
state of the protein remaining in the cell culture medium was analyzed on a BioSil
HPLC size exclusion column (Bio-Rad, Hercules, CA, USA) on an AKTA FPLC
(GE Healthcare). Gel ﬁltration molecular weight standards (Bio-Rad) were used
(thyroglobulin, bovine g-globulin, chicken ovalbumin, equine myoglobin, and
vitamin B12). The column was calibrated with 0.1ml of the standards at a ﬂow rate
of 0.1ml/min using 0.05M Na2HPO4, 0.05M NaH2PO4, 0.15M NaCl, 0.01M NaN3,
pH 7.4 buffer. A calibration curve was determined by plotting the log molecular
weight of the standards as a function of the elution volume. Media alone and
soluble,freshlyﬁlteredproteindissolvedinmediawereinjectedto serveasbaseline
for our experiments. A line of best ﬁt was calculated to determine the molecular
weight of the peaks in the protein samples.
Western blot. After size exclusion chromatography was performed on the
protein remaining in the media, the fractions containing protein were frozen
at  801C, thawedat a later date, andrun on denaturing15% SDS-PAGEgels.The
gel was then transferred to an Immobilon P (PVDF) membrane as reported
previously.
27 The primary antibody used was a sheep anti-human k-light chain with
adilutionof 1:500(TheBindingSiteInc.,SanDiego,CA,USA), andthesecondary
antibody used was a rabbit anti-sheep polyclonal IgG H and L (HRP) antibody
(Abcam Inc., Cambridge, MA, USA). The dilution for the secondary antibody was
1:8000 for the 48 and 72h gels and 1:4000 for the 24h gels.
Fibril formation. Fibril-formation samples were set up in triplicate with 20mM
protein,5mM ThT, and10mMTris-HCl buffer, pH 7.4in a 96-wellblack polystyrene
plate. Plates were incubated at 371C with constant agitation at 250r.p.m. The plate
was read on the Analyst AD plate reader (Molecular Devices) at an excitation
wavelength of 440nm and emission wavelength of 480nm. Average values were
calculated for each protein. Soluble AL-09 and kI O18/O8 were centrifuged to the
sedimentation time of a 0.5S particle
28 before the ﬁbril-formation reaction, whereas
AL-12 was ﬁltered before the reaction.
Electron microscopy. A3 ml aliquot of each sample was placed on a
300-mesh copper/formvar carbon grid and air dried. Grids were negatively stained
with 2% uranyl acetate, washed, air dried and examined on a Phillips Tecnai T12
transmission electron microscope (FEI Inc., Hillsboro, OR, USA).
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